Search Results - "George, Jacob"
-
1
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Published in Nature reviews. Gastroenterology & hepatology (01-01-2020)“…Nonalcoholic fatty liver disease (NAFLD) affects around a quarter of the global population, paralleling worldwide increases in obesity and metabolic syndrome…”
Get full text
Journal Article -
2
Adding to the confusion in more than just the name
Published in Clinical and molecular hepatology (01-10-2023)“…Subsequent years have seen more than 4,000 citations for the two sentinel papers, over 7,000 publications using the MAFLD terminology and definition, and…”
Get full text
Journal Article -
3
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Published in Hepatology (Baltimore, Md.) (01-06-2019)“…Over the past 2 decades, nonalcoholic fatty liver disease (NAFLD) has grown from a relatively unknown disease to the most common cause of chronic liver disease…”
Get full text
Journal Article -
4
TREM2 as an evolving therapeutic target in Alzheimer's disease
Published in Neural regeneration research (01-12-2023)Get full text
Journal Article -
5
Genetic Insights for Drug Development in NAFLD
Published in Trends in pharmacological sciences (Regular ed.) (01-07-2019)“…Drug development is a costly, time-consuming, and challenging endeavour, with only a few agents reaching the threshold of approval for clinical use. Therefore,…”
Get full text
Journal Article -
6
Cytokines: From Clinical Significance to Quantification
Published in Advanced science (01-08-2021)“…Cytokines are critical mediators that oversee and regulate immune and inflammatory responses via complex networks and serve as biomarkers for many diseases…”
Get full text
Journal Article -
7
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Published in Nature reviews. Gastroenterology & hepatology (01-03-2019)“…Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype nonalcoholic steatohepatitis (NASH) are becoming the leading cause…”
Get full text
Journal Article -
8
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
Published in Hepatology research (01-11-2021)“…Aim Metabolic associated fatty liver disease (MAFLD) partly overlaps with non‐alcoholic fatty liver disease (NAFLD). Thus, using a generalized estimating…”
Get full text
Journal Article -
9
MAFLD: How is it different from NAFLD?
Published in Clinical and molecular hepatology (01-02-2023)“…"Metabolic dysfunction-associated fatty liver disease (MAFLD)" is the term suggested in 2020 to refer to fatty liver disease related to systemic metabolic…”
Get full text
Journal Article Book Review -
10
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Published in Liver international (01-12-2020)“…Background & Aims Diagnostic criteria for metabolic associated fatty liver disease (MAFLD) have been proposed, but not validated. We aimed to compare the…”
Get full text
Journal Article -
11
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Published in Nature reviews. Gastroenterology & hepatology (01-01-2018)“…Key Points As a consequence of the pandemic spread of obesity, NAFLD is one of the most important causes of liver disease worldwide in adults and children,…”
Get full text
Journal Article -
12
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Published in Hepatology (Baltimore, Md.) (01-04-2020)“…Background and Aims Nonalcoholic fatty liver disease (NAFLD) affects a quarter of the adult population. A significant subset of patients are lean, but their…”
Get full text
Journal Article -
13
Role of nanomaterials in water treatment applications: A review
Published in Chemical engineering journal (Lausanne, Switzerland : 1996) (15-12-2016)“…•Use of nanomaterials (NMs) in water treatment has been reviewed.•Carbon nanomaterials, nano metal oxides and nano composites are reviewed.•Adsorption,…”
Get full text
Journal Article -
14
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
Published in Molecular cancer (23-10-2017)“…Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor prognosis worldwide. While early stage tumours can be treated with…”
Get full text
Journal Article -
15
Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models
Published in Journal of neuroinflammation (09-01-2021)“…Genetic variants and mutations in triggering receptor expressed in myeloid cells (TREM2) are associated with premature and late onset Alzheimer's disease (AD)…”
Get full text
Journal Article -
16
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Published in Clinical and molecular hepatology (01-04-2022)“…Fatty liver is now a major cause of liver disease in the Asia-Pacific region. Liver diseases in this region have distinctive characteristics. First, fatty…”
Get full text
Journal Article Book Review -
17
Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer research
Published in Cancer letters (28-06-2021)“…Primary liver cancer (PLC) represents a significant proportion of all human cancers and constitutes a substantial health and economic burden to society…”
Get full text
Journal Article -
18
Single cell RNA-seq analysis identifies a noncoding RNA mediating resistance to sorafenib treatment in HCC
Published in Molecular cancer (03-01-2022)“…Despite showing upregulation of stemness/EMT genes, Huh7-R cells showed downregulation of the proliferative marker MKI67, and cell-cycle related genes (Fig…”
Get full text
Journal Article -
19
Nonalcoholic fatty liver disease burden: Australia, 2019–2030
Published in Journal of gastroenterology and hepatology (01-09-2020)“…Background and Aim Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) account for a large and growing proportion of liver disease…”
Get full text
Journal Article -
20
Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes
Published in Journal of the American College of Cardiology (24-12-2019)“…E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers…”
Get full text
Journal Article